Greater utility of molecular subtype rather than epithelial‐to‐mesenchymal transition ( EMT ) markers for prognosis in high‐risk non‐muscle‐invasive ( HGT1 ) bladder cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Greater utility of molecular subtype rather than epithelial‐to‐mesenchymal transition (
EMT
) markers for prognosis in high‐risk non‐muscle‐invasive (
HGT1
) bladder cancer
Authors
Keywords
-
Journal
Journal of Pathology Clinical Research
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-05-06
DOI
10.1002/cjp2.167
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Therapeutic implications of cancer epithelial-mesenchymal transition (EMT)
- (2019) Eunae Sandra Cho et al. ARCHIVES OF PHARMACAL RESEARCH
- Stromal lymphocyte infiltration is associated with tumour invasion depth but is not prognostic in high-grade T1 bladder cancer
- (2019) Mathieu Rouanne et al. EUROPEAN JOURNAL OF CANCER
- The prognostic relevance of FOXA1 and Nestin expression in breast cancer metastases: a retrospective study of 164 cases during a 10-year period (2004–2014)
- (2019) Shahin De Lara et al. BMC CANCER
- EMT and Cancer: More Than Meets the Eye
- (2019) Rik Derynck et al. DEVELOPMENTAL CELL
- Clinical parameters outperform molecular subtypes for predicting outcome in bladder cancer: Results from multiple cohorts including TCGA
- (2019) Daley S. Morera et al. JOURNAL OF UROLOGY
- Molecular subtypes applied to a population-based modern cystectomy series do not predict cancer-specific survival
- (2019) Petter Kollberg et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Dysregulation of EMT Drives the Progression to Clinically Aggressive Sarcomatoid Bladder Cancer
- (2019) Charles C. Guo et al. Cell Reports
- European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update
- (2019) Marko Babjuk et al. EUROPEAN UROLOGY
- A Consensus Molecular Classification of Muscle-invasive Bladder Cancer
- (2019) Aurélie Kamoun et al. EUROPEAN UROLOGY
- Staging of bladder cancer
- (2018) Martin J Magers et al. HISTOPATHOLOGY
- High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors
- (2018) Saman Maleki Vareki Journal for ImmunoTherapy of Cancer
- QuPath: Open source software for digital pathology image analysis
- (2017) Peter Bankhead et al. Scientific Reports
- Sarcomatoid Urothelial Carcinoma of the Bladder: Analysis of 28 Cases With Emphasis on Clinicopathologic Features and Markers of Epithelial-to-Mesenchymal Transition
- (2016) Joseph Sanfrancesco et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- WHO 1973 grade 3 and infiltrative growth pattern proved, aberrant E-cadherin expression tends to be of predictive value for progression in a series of stage T1 high-grade bladder cancer after organ-sparing approach
- (2016) Wolfgang Otto et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Fully Automated RNAscope In Situ Hybridization Assays for Formalin-Fixed Paraffin-Embedded Cells and Tissues
- (2016) Courtney M. Anderson et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Specific micro-RNA expression patterns distinguish the basal and luminal subtypes of muscle-invasive bladder cancer
- (2016) Andrea E. Ochoa et al. Oncotarget
- Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use
- (2016) Vipulkumar Dadhania et al. EBioMedicine
- New Insights into the Crossroads between EMT and Stemness in the Context of Cancer
- (2016) Isabel Fabregat et al. Journal of Clinical Medicine
- FOXA1, GATA3 and PPARɣ Cooperate to Drive Luminal Subtype in Bladder Cancer: A Molecular Analysis of Established Human Cell Lines
- (2016) Joshua I. Warrick et al. Scientific Reports
- Expression profile of epithelial-mesenchymal transition markers in non–muscle-invasive urothelial carcinoma of the bladder: Correlation with intravesical recurrence following transurethral resection
- (2015) Bing Liu et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
- (2014) R. Salgado et al. ANNALS OF ONCOLOGY
- Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial–mesenchymal transition (EMT) to mesenchymal–epithelial transition (MET) states
- (2014) T Yoshida et al. BRITISH JOURNAL OF CANCER
- Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy
- (2014) Woonyoung Choi et al. CANCER CELL
- Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology
- (2014) J. S. Damrauer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Molecular Taxonomy for Urothelial Carcinoma
- (2012) G. Sjodahl et al. CLINICAL CANCER RESEARCH
- Vimentin in cancer and its potential as a molecular target for cancer therapy
- (2011) Arun Satelli et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Domain and Functional Analysis of a Novel Breast Tumor Suppressor Protein, SCUBE2
- (2011) Yuh-Charn Lin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Tumor-Infiltrating CD8+ Lymphocytes Predict Clinical Outcome in Breast Cancer
- (2011) Sahar M.A. Mahmoud et al. JOURNAL OF CLINICAL ONCOLOGY
- Overexpression of receptor tyrosine kinase Axl promotes tumor cell invasion and survival in pancreatic ductal adenocarcinoma
- (2010) Xianzhou Song et al. CANCER
- Expression of transcription factors snail, slug, and twist in human bladder carcinoma
- (2010) Qinchao Yu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer
- (2010) K Vuoriluoto et al. ONCOGENE
- An Updated Critical Analysis of the Treatment Strategy for Newly Diagnosed High-grade T1 (Previously T1G3) Bladder Cancer
- (2009) Girish S. Kulkarni et al. EUROPEAN UROLOGY
- Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer
- (2009) Carsten Denkert et al. JOURNAL OF CLINICAL ONCOLOGY
- Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival
- (2009) C. Gjerdrum et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now